Christer Fuglesang
Angel Investor
Stockholm, Sweden
Christer Fuglesang is a pre-seed investor in Stockholm focused on Medical and Robotics. Christer Fuglesang flew as Mission Specialist on Space ShuttleDiscoveryfor STS-116 to the International Space Station. He became the first Swedish astronaut to fly in space. During his Celsius mission, Christer conducted three spacewalks. His tasks were to attach new hardware to the Station and to reconfigure the Station’s electrical power system.The unscheduled third spacewalk freed the Station’s jammed P6 solar array. His total spacewalk time during the mission was 18 hours 14 minutes.Christer‘s second spaceflight lasted from 29 August to 12 September 2009. He was Mission Specialist on Space ShuttleDiscoveryfor STS-128 to the International Space Station. On this Alissé mission, Christer made two spacewalks, installing an ammonia tank and preparing for the installation of the European-built Node-3 module. He spent 13 hours and 40 minutes spacewalking, bringing his total time spent spacewalking to 31 hours and 54 minutes. Christer was also responsible for overseeing cargo transfers from the Leonardo Multi-Purpose Logistics Module that was brought to the Station inDiscovery. Christer also performed experiments and educational and public relations activities.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Christer Fuglesang invests in
Stages Christer Fuglesang invests in
Countries Christer Fuglesang invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (50%)
- Robotics 1 (50%)
- E-Commerce 1 (50%)
- Health Care 1 (50%)
- Marketplace 1 (50%)
Stage
- Pre-Seed 1 (50%)
- Venture - Series Unknown 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Dropmed is a Stockholm-based startup aiming to digitally transform medical device sales by providing groundbreaking tools for E-Commerce enablement and guided purchasing. | $323.7K / Pre-Seed / Jan 30, 2022 | ||
| Bioservo Technologies is a Stockholm based start-up company founded in 2006 as the result of a collaboration between scientists at the Karolinska Institute and the Royal Institute of Technology. The mission of Bioservo Technologies is to develop muscle strengthening devices based on the patented SEMâ„¢ technology. The first product is theSEMâ„¢Glove which will be introduced to the Swedish market in the fall of 2009. SEMâ„¢Glove will eventually be introduced to a global market. The SEMâ„¢ technology is developed by Johan Ingvast who also is the current CEO of Bioservo and he runs the company together with a highly motivated team of 4 persons. | Venture - Series Unknown / May 18, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Christer Fuglesang invest in?
Christer Fuglesang invests primarily in Medical, Robotics and E-Commerce startups, most often at Pre-Seed and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Christer Fuglesang?
Public channels for Christer Fuglesang include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Christer Fuglesang last invest?
The most recent investment recorded for Christer Fuglesang closed in Jan 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
